CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 56 filers reported holding CABALETTA BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,170,239 | +68.4% | 2,442,197 | +42.8% | 0.00% | 0.0% |
Q2 2023 | $22,072,459 | +1050.7% | 1,709,718 | +637.1% | 0.00% | – |
Q1 2023 | $1,918,226 | -20.9% | 231,950 | -11.6% | 0.00% | – |
Q4 2022 | $2,426,322 | +751.3% | 262,305 | -40.1% | 0.00% | – |
Q3 2022 | $285,000 | -46.1% | 437,984 | -12.2% | 0.00% | – |
Q2 2022 | $529,000 | -49.0% | 498,791 | -2.3% | 0.00% | – |
Q1 2022 | $1,037,000 | -45.7% | 510,587 | +1.3% | 0.00% | – |
Q4 2021 | $1,910,000 | -52.5% | 504,190 | +52.6% | 0.00% | – |
Q3 2021 | $4,019,000 | +47.4% | 330,481 | +4.2% | 0.00% | – |
Q2 2021 | $2,727,000 | -76.6% | 317,188 | -69.8% | 0.00% | – |
Q1 2021 | $11,640,000 | -2.0% | 1,048,564 | +10.2% | 0.00% | – |
Q4 2020 | $11,874,000 | +73.2% | 951,396 | +50.4% | 0.00% | – |
Q3 2020 | $6,857,000 | -1.2% | 632,397 | +1.6% | 0.00% | – |
Q2 2020 | $6,937,000 | +208.2% | 622,683 | +102.0% | 0.00% | – |
Q1 2020 | $2,251,000 | -32.2% | 308,282 | +29.8% | 0.00% | – |
Q4 2019 | $3,319,000 | – | 237,538 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 2,064,263 | $4,190,000 | 0.92% |
Kynam Capital Management, LP | 616,125 | $1,251,000 | 0.41% |
Ikarian Capital, LLC | 1,020,070 | $2,070,000 | 0.27% |
Cormorant Asset Management, LP | 1,154,424 | $2,343,000 | 0.18% |
Ikarian Capital, LLC | 449,000 | $912,000 | 0.12% |
HARBOR CAPITAL ADVISORS, INC. | 119,315 | $242,000 | 0.11% |
Boxer Capital, LLC | 540,000 | $1,096,000 | 0.06% |
SAMLYN CAPITAL, LLC | 1,768,083 | $3,589,000 | 0.05% |
Redmile Group, LLC | 696,377 | $1,414,000 | 0.04% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 464,252 | $942,000 | 0.02% |